A Synthetic Vaccine

Synthetic biology could help hasten vaccine development, writes Susan Young at MIT's Technology Review. She writes that Novartis is trying out chemically synthesizing viral genomes to grow in tissue culture rather than the standard approach of growing flu viruses up in chicken eggs for vaccine production.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.